As part of a clinical study, the Early Clinical Trial Unit (ECTU) at NCT/UCC Dresden tested the cancer immunotherapy IMA401 for the first time in patients with advanced solid tumors. IMA401 is a ...

New research shows a novel pill is helping people with advanced pancreatic cancer live longer. It's not a cure, as the drug's ...

The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.

An injection that eradicated entire tumours in patients with otherwise treatment-resistant cancers in a trial has been praised for its "striking" benefits.

A cell copies all of its DNA, gears up to split in two, and then just… doesn’t. It sits there, swollen with a double genome, ...

A targeted treatment designed to trigger the death of cancer cells has shown significant promise for patients with advanced bowel cancer when combined with chemotherapy, an early trial has revealed.

Scientists at the world's largest cancer conference have hailed the start of a new drug 'revolution'.

A newly discovered genetic link between cat and human cancer may have major implications for the disease’s treatment in both ...

MOST people pray they won’t be struck with cancer even once in a lifetime – let alone 170 times. But that’s the reality for Sean Breininger, who is nothing short of a miracle, having ...

A pill that doubles life expectancy in patients with pancreatic cancer has been hailed as the biggest breakthrough for decades. Doctors are billing daraxonrasib as a “revolution” in cancer treatment, ...

A CANCER jab available on the NHS can melt away tumours when patients have run out of options, a trial found. Triple-action injection amivantamab works by blocking a growth protein and an enzyme ...

A lung cancer drug from China's Akeso, ivonescimab, extended patients' lives by about four months in a late-stage trial. Read ...